Versant Capital Management »

Soleno Therapeutics shares owned by Versant Capital Management

Quarter-by-quarter ownership of Soleno Therapeutics (SLNO) shares owned by Versant Capital Management from 13F filings

Historical chart of Versant Capital Management investment in Soleno Therapeutics

23:59:59.999Dec 30, 202423:59:59.999500:00:00Dec 31, 202400:00:00.000500:00:00.00137293,729.537303,730.537318282.58383.584
Value ($)Share countHistorical SLNO position of Versant Capital Management Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Soleno Therapeutics held by Versant Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Soleno Therapeutics by Versant Capital Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $3.7k 83 44.95

More positions owned by Versant Capital Management

Avantis International Equity Etf Etf (AVDE)
Vanguard Emerging Markets Government Bond Etf Etf (VWOB)
Dimensional U.s. Core Equity 2 Etf Etf (DFAC)
Avantis Emerging Markets Equity Etf Etf (AVEM)
Flexshares Tr Mornstar Upstr Etf (GUNR)
Microsoft Stock (MSFT)
Ishares S&p Global Energy Etf (IXC)
Dimensional International Core Equity 2 Etf Etf (DFIC)
Vaneck Gold Miners Etf Etf (GDX)
Vanguard Total Stk Mkt Etf (VTI)
Global X Fds Global X Ftse Greece 20 Etf Etf (GREK)
Exxon Mobil Corp Stock (XOM)
Apple Stock (AAPL)
Spdr S&p Global Natural Resources Etf Etf (GNR)
Spdr Gold Minishares Trust Etf (GLDM)

View all positions for Versant Capital Management

Top funds holding Soleno Therapeutics

Vivo Capital
Henderson Group
Nantahala Capital Management
Adage Capital Partners GP
Susquehanna International
venBio Select Advisor
BlackRock
Vanguard Group
T. Rowe Price Associates
Perceptive Advisors
Carlyle
State Street Corporation
Citadel Advisors
Commodore Capital
Caption Management

View all funds holding Soleno Therapeutics